Evaluating the Revised WORQ in CI Users

October 26, 2020 updated by: Griet Mertens, University Hospital, Antwerp

Evaluating the Revised Work Rehabilitation Questionnaire in Cochlear Implant Users

The Work Related Questionnaire (WORQ) is a 59-item questionnaire of which each item represents an International Classification of Functioning and disability category. The WORQ was modified and reduced to include only questions relevant to Cochlear Implant (CI) users. In this analysis, a multicentre retrospective review of the revised WORQ in CI users was performed, with the revised WORQ as part of the questionnaires used in the regular clinical follow-up of CI users. Experienced CI users' responses on the questions will be evaluated to define the qualifiers for the revised WORQ.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

177

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Perth, Australia
        • Fiona Stanley Fremantle Hospital Group
      • Edegem, Belgium
        • University Hospital Antwerp
      • Würzburg, Germany
        • University Clinic of Würzburg
      • Kajetany, Poland
        • World Hearing Centre
      • Madrid, Spain
        • Hospital La Paz

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Experienced adult CI users

Description

Inclusion Criteria:

  • Adults over the age of 18 years
  • Adults must wear a MED-EL cochlear implant
  • Adults may have the following hearing indications and device fitting:

    • Unilateral cochlear implant with severe-to-profound hearing loss
    • Bilateral cochlear implant with severe-to-profound hearing loss
    • Single sided deafness (SSD) where the poorer ear PTA ≥70 dB HL and the better ear PTA ≤30 dB HL with an interaural threshold gap of ≥40 dB HL.
    • Asymmetrical hearing loss using a cochlear implant in the poorer ear and a hearing aid in the better ear (also known as bimodal fitting). The poorer ear PTA ≥70 dB HL and the better ear PTA >30 dB HL and ≤55 dB HL with an interaural threshold gap of ≥15 dB HL.
  • Adults should have a minimum of one year's device experience

Exclusion Criteria

No extra exclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
CI users

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Completion of the WORQ questionnaire
Time Frame: One test interval, at least one year after Cochlear Implantation

Part 1: Work situation and educational background of participants

  • School education
  • Remunerative employment

Part 2: Daily life functioning of participants

  • Emotional functions
  • Vestibular functions
  • Carrying out daily routine
  • Stress
  • Conversation
  • Communication devices and techniques
  • Tinnitus and dizziness
  • Community life
  • Family relationships

Part I addresses demographics and relevant background information. In Part 2, participants have to rate to what extent they had problems with a certain task or activity in the last week based on a numerical scale ranging from 0 (no problem) to 10 (complete problem).

Each individual WORQ item is linked to an ICF qualifier, which is a numerical code that specifies the extent or magnitude of functioning or disability in that ICF category or the extent to which a contextual factor is a facilitator or barrier.

One test interval, at least one year after Cochlear Implantation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 4, 2019

Primary Completion (Actual)

July 13, 2020

Study Completion (Actual)

July 13, 2020

Study Registration Dates

First Submitted

October 20, 2020

First Submitted That Met QC Criteria

October 20, 2020

First Posted (Actual)

October 26, 2020

Study Record Updates

Last Update Posted (Actual)

October 28, 2020

Last Update Submitted That Met QC Criteria

October 26, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hearing Loss

Subscribe